Free Trial

CME Group Inc. $CME Shares Purchased by NewEdge Advisors LLC

CME Group logo with Finance background

Key Points

  • NewEdge Advisors LLC increased its stake in CME Group Inc. by 3.8%, holding 55,161 shares valued at approximately $14.63 million as of the latest SEC filing.
  • The firm announced a quarterly dividend of $1.25 per share, yielding 1.9%, with a payout ratio of 48.40%.
  • CME Group's recent earnings report revealed an EPS of $2.96, exceeding analysts' expectations, alongside a year-over-year revenue increase of 10.4% to $1.69 billion.
  • MarketBeat previews top five stocks to own in October.

NewEdge Advisors LLC raised its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 3.8% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 55,161 shares of the financial services provider's stock after buying an additional 2,043 shares during the period. NewEdge Advisors LLC's holdings in CME Group were worth $14,634,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Nippon Life Global Investors Americas Inc. acquired a new position in CME Group in the first quarter valued at approximately $1,276,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in CME Group by 161.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 168,938 shares of the financial services provider's stock worth $44,817,000 after purchasing an additional 104,352 shares during the period. Integrated Wealth Concepts LLC raised its holdings in CME Group by 9.8% in the 1st quarter. Integrated Wealth Concepts LLC now owns 2,667 shares of the financial services provider's stock worth $707,000 after purchasing an additional 238 shares during the period. Gotham Asset Management LLC boosted its position in CME Group by 4.9% during the first quarter. Gotham Asset Management LLC now owns 90,205 shares of the financial services provider's stock worth $23,930,000 after purchasing an additional 4,228 shares in the last quarter. Finally, Cinctive Capital Management LP acquired a new stake in CME Group in the first quarter valued at approximately $240,000. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Price Performance

CME stock traded down $1.62 during midday trading on Wednesday, reaching $259.91. The stock had a trading volume of 1,630,640 shares, compared to its average volume of 2,303,762. The company's fifty day simple moving average is $274.42 and its 200 day simple moving average is $270.18. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market cap of $93.67 billion, a price-to-earnings ratio of 25.16, a price-to-earnings-growth ratio of 4.75 and a beta of 0.43. CME Group Inc. has a 52-week low of $212.38 and a 52-week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the firm earned $2.56 EPS. The company's quarterly revenue was up 10.4% compared to the same quarter last year. As a group, sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's payout ratio is currently 48.40%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. UBS Group reduced their target price on CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a research note on Monday. Oppenheimer upped their price objective on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research report on Thursday, July 24th. Piper Sandler upped their price objective on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. Erste Group Bank cut shares of CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Finally, Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Four investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, CME Group has a consensus rating of "Hold" and an average price target of $260.60.

Get Our Latest Research Report on CME Group

Insider Buying and Selling at CME Group

In other news, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider owned 17,440 shares in the company, valued at $4,734,436.80. The trade was a 40.55% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William R. Shepard purchased 256 shares of CME Group stock in a transaction dated Wednesday, June 25th. The shares were bought at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the acquisition, the director owned 258,196 shares in the company, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.30% of the stock is owned by insiders.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.